SONOSCAPE(SZ:300633) Zheng Quan Zhi Xing·2025-09-05 12:19Core Viewpoint - Shenzhen Kaili Biomedical Technology Co., Ltd. is implementing a stock incentive plan to attract and retain talent, aligning the interests of shareholders, the company, and employees for long-term development [1][2]. Summary by Sections 1. Purpose of Assessment - The assessment aims to establish a long-term incentive mechanism to attract and retain talent, enhancing employee motivation and creativity while aligning the interests of shareholders, the company, and employees [1]. 2. Principles of Assessment - The assessment must adhere to principles of fairness, openness, and impartiality, closely linking the stock incentive plan with the performance and contributions of the incentivized individuals to maximize the interests of the company and all shareholders [2]. 3. Assessment Targets - The assessment applies to all participants in the stock incentive plan, including certain directors, senior management, middle management, and key technical personnel, excluding independent directors, supervisors, foreign employees, and shareholders holding more than 5% of the company's shares [2]. 4. Assessment Organization - The Board of Directors' Compensation and Assessment Committee is responsible for organizing and reviewing the assessment, while a working group composed of the Board Office, Human Resources Department, and Finance Department will implement the assessment [2]. 5. Assessment Indicators and Standards - The performance assessment for the stock incentive plan spans from 2025 to 2028, with specific net profit growth targets set for each year based on the 2024 net profit of 136.49 million yuan, requiring growth rates of at least 30% in 2025, 70% in 2026, 150% in 2027, and 260% in 2028 [3]. 6. Implementation of the Plan - If the company fails to meet the performance targets in any assessment year, the corresponding restricted stocks and stock options for that year will not vest or be exercised, and will be rendered void [3][4]. 7. Assessment Period and Frequency - The assessment period for the stock incentive plan is set for four accounting years from 2025 to 2028, with assessments conducted annually [4]. 8. Assessment Procedure - The assessment working group collects relevant business and financial data, evaluates whether the company and individuals meet the performance targets, and submits a performance assessment report to the Compensation and Assessment Committee [4][5]. 9. Management of Assessment Results - Assessment results will be communicated to the assessed individuals within seven working days, allowing for appeals, which must be reviewed within five working days [5].